Remicade (anti tumor necrosis factor inhibitor)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
40Takayasu arteritis1

40. Takayasu arteritis    [ 22 clinical trials,   46 drugs,   (DrugBank: 20 drugs),   22 drug target genes,   111 drug target pathways]
Searched query = "Takayasu arteritis", "Aortitis syndrome", "Pulseless disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 22 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02457585
(ClinicalTrials.gov)
March 201518/5/2015Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu ArteritisAnti-tumor Necrosis Factor Therapy Effect on Takayasu ArteritisTakayasu's ArteritisDrug: remicade (anti tumor necrosis factor inhibitor)Seoul National University HospitalNULLRecruiting18 YearsN/AAll11Phase 2Korea, Republic of